Belmac
This article was originally published in The Tan Sheet
Executive Summary
Forms joint venture agreement with New York-based health care firm Maximed to develop and introduce an extended-release vaginal contraceptive with nonoxynol-9 that will be self-administered with a biodegradable tubular applicator. Nonoxynol-9 will be incorporated into a "hydrogel-based delivery system" developed by Maximed. The firms expect to launch the product in the U.S. in early 1995
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning